A Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis

Phase 2 Completed ICOS Corporation

RandomizedParallel-groupDouble-blindTreatment

Summary

The objective of this study is to demonstrate the safety and efficacy of IC14 in the treatment of hospitalized patients with community-acquired pneumonia and sepsis.

Timeline

Start: 2002-05
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	IC14	Monoclonal antibody	—	—

A Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis

Summary

Timeline

Drugs

Indications